$ParkwayLife Reit(C2PU.SG)

Parkway Life REIT (C2PU): Strong DPU Growth, But Price Matters

Parkway Life REIT delivered a strong 1H26, with DPU rising 14.6% y/y to 8.77 cents, driven by step-up lease arrangements across its Singapore hospitals and France portfolio. Singapore remains the earnings anchor, contributing about 68% of gross revenue, while Japan and France provide diversification. (Grow Beansprout⁠)

Financial quality remains robust: gearing is around 34%, interest coverage 8.4x, all-in debt cost 1.66%, and 96% of interest exposure is hedged. Debt maturities are well staggered, with no major long-term refinancing requirement until March 2027. This compares favourably with Keppel DC REIT’s 34% gearing and 6.9x coverage, while MIT is more leveraged at 37.5% with 4.0x coverage. (DBS Singapore⁠)

The key risk is concentration: Singapore’s CPI-linked leases currently subsidise weaker JPY translation and Japan tenant disruption. Yen depreciation remains an earnings headwind, while Europe carries operator, regulatory and macroeconomic uncertainty. However, FX income hedges through 2029/30 provide meaningful protection. (DBS Singapore⁠)

Technically, the REIT remains constructive, trading above its 200-day moving average, although momentum has moderated. (Investing⁠)

At roughly 1.5–1.6x P/B, valuation is not cheap. Its five-year historical P/B average is about 1.7x; hence the current discount is modest rather than a clear statistical bargain. (SG Investors⁠)

Verdict: HOLD/ACCUMULATE ON WEAKNESS. A more compelling entry would be around 1.2–1.3x P/B, historically around the attractive-discount zone. (SG Investors⁠)

Not financial advice.

The main takeaway is that PLife REIT has one of the stronger balance sheets among comparable S-REITs, but investors are already paying a premium for that quality. At current valuation, the margin of safety is less compelling than the underlying fundamentals.